CClinicalTrials.gg
CompletedNCT03243162Updated May 20, 2020

Improving ACL Reconstruction Outcomes: CBPT

An interventional study of CBPT-ACLR and Education in ACL Injury, ACL - Anterior Cruciate Ligament Rupture and ACL Sprain, sponsored by Vanderbilt University Medical Center. Completed at 2 sites in United States. Open to participants aged 14 Years to 35 Years. Per ClinicalTrials.gov, last updated 2020-05-20.

Sponsored by Vanderbilt University Medical Center · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
90
Allocation
Randomized
Ages
14 Years to 35 Years
Sex
All
01

Study summary

The overall objective of this study is to conduct a two-group randomized trial to examine the efficacy of cognitive-behavioral based physical therapy (CBPT) for improving knee function, return to sport, and quality of life outcomes in patients following ACL reconstruction (ACLR). The study consists of two treatment groups: telephone-based cognitive-behavioral based physical therapy for ACLR (CBPT-ACLR) and telephone-based Education. The central hypothesis is that the CBPT-ACLR participants relative to the Education group will demonstrate significantly greater improvement in postoperative outcomes at 12 months following surgery.

02

Conditions studied

  • ACL Injury
  • ACL - Anterior Cruciate Ligament Rupture
  • ACL Sprain
  • ACL Tear
03

In context

Rupture

557 studies on the registry are indexed under Rupture; 97 are open to participants now.

This study's enrollment of 90 is above the median of 72 across 334 interventional studies indexed under Rupture.

Browse Rupture studies →

Lead sponsor

Vanderbilt University Medical Center is the lead sponsor of 824 studies on the registry; 164 are open to participants now.

Of its 122 completed or terminated interventional studies of FDA-regulated products, 91 (75%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
14 Years to 35 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  1. English speaking (due to feasibility of employing study personnel to deliver and assess the study intervention);
  2. 14 to 35 years of age (children 14 and older have skeletal maturity and adults 35 and younger are less likely to have symptoms of knee osteoarthritis);
  3. no previous surgery to either knee;
  4. time from injury to surgery 12 months or less;
  5. active participation in a sport on a weekly basis prior to injury

Exclusion criteria

Exclusion Criteria:

  1. bilateral simultaneous ACL reconstructions;
  2. revision ACLR;
  3. any concurrent ligament (MCL, LCL, or PCL) surgical procedures;
  4. concurrent osteotomies or meniscus transplantations;
  5. surgery secondary to trauma, tumor, or infection;
  6. having workman's compensation insurance for surgery;
  7. on active military duty;
  8. medical history of schizophrenia or other psychotic disorder; and
  9. unable to provide stable address and access to a telephone
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Investigator, Outcomes assessor)
Enrollment
90 participants (actual)

Study arms

  • Experimental
    CBPT-ACLR

    CBPT-ACLR program consisting of weekly phone calls.

    Behavioral: CBPT-ACLR

  • Active comparator
    Education

    Education program consisting of weekly phone calls.

    Other: Education

Interventions

  • BehavioralCBPT-ACLR

    The CBPT-ACLR program focuses on improving sports function and return to sport. CBPT-ACLR sessions cover realistic expectations, relaxation strategies, problem-solving training, cognitive restructuring, and behavioral self-management (i.e., graded activity, goal setting, managing setbacks and symptom management plans). Each session builds upon the content of the previous session using an action plan and weekly homework is personally tailored based on patient goals. The program consists of one preoperative telephone session and six postoperative telephone sessions with a physical therapist. Each patient randomized into the CBPT-ACLR program will receive a manual to follow along with the study therapist.

  • OtherEducation

    The education program focuses on postoperative ACLR recovery. Sessions address benefits of physical therapy, proper biomechanics during sports and other functional activity, importance of early exercise after surgery, and ways to promote healing. Education on stress reduction, sleep hygiene, energy management, communication with health providers, and preventing future injury are also provided. The Education program is matched to the CBPT-ACLR treatment in terms of session frequency, length and contact with the study therapist. Each patient randomized into the Education program will receive a manual to follow along with the study therapist.

06

What researchers measure

Primary outcomes

  1. Knee Injury and Osteoarthritis Outcome Score (KOOS) sport and recreation sub-scale

    knee function relating to sport/recreation

    Time frame: Up to 12 months after ACLR surgery

  2. Marx Activity Rating Scale

    The Marx Activity Rating Scale measures knee function relating to running, cutting, decelerating, and pivoting.

    Time frame: Up to 12 months after ACLR surgery

Secondary outcomes

  1. Subjective Patient Outcome for Return to Sports (SPORTS)

    The SPORTS score measures 1) ability to perform the same sport with the same level of effort, 2) ability to reach the same level of performance, and 3) ability to perform with no pain or in spite of the pain.

    Time frame: Up to 12 months after ACLR surgery

  2. Knee Injury and Osteoarthritis Outcome Score (KOOS) knee related quality of life sub-scale

    knee function relating to quality of life

    Time frame: Up to 12 months after ACLR surgery

  3. EQ-5D

    The EQ-5D is used to measure non-disease-specific quality of life and calculate cost-effectiveness.

    Time frame: Up to 12 months after ACLR surgery

07

Study locations

2 sites
  • Cleveland Clinic
    Garfield Heights, Ohio 44125, United States
  • Vanderbilt University Medical Center
    Nashville, Tennessee 37232, United States
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 20, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT03243162
Lead sponsor
Vanderbilt University Medical Center
Collaborators
The Cleveland Clinic
Responsible party
Kristin Archer (Associate Professor and Vice Chair of Research, Vanderbilt University Medical Center) — Principal investigator
First posted
Aug 8, 2017
Start date
Jul 1, 2017
Primary completion
Feb 18, 2020
Completion
Apr 17, 2020
Last update
May 20, 2020

Study contacts

Kristin Archer, PhD, DPT
principal investigator · Vanderbilt University Medical Center

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion